a public good project by the
Synthesis
Company
of California

© 2026

Paul Brookes | doi.page

0 works0 citations0 h-index

Paul Brookes

Guy's and St Thomas' NHS Foundation Trust(GB)Harefield Hospital(GB)

Publications by Year

Research Areas

Renal Transplantation Outcomes and Treatments, T-cell and B-cell Immunology, Hematopoietic Stem Cell Transplantation, Renal Diseases and Glomerulopathies, Immunotherapy and Immune Responses

Most-Cited Works

→ De Novo DQ Donor-Specific Antibodies Are Associated With a Significant Risk of Antibody-Mediated Rejection and Transplant Glomerulopathy(2012)245 cited
→ Loss of Direct and Maintenance of Indirect Alloresponses in Renal Allograft Recipients: Implications for the Pathogenesis of Chronic Allograft Nephropathy(2001)208 cited
Prediction of graft versus host disease by frequency analysis of cytotoxic T cells after unrelated donor bone marrow transplantation.(1989)
→ Circulating complement factor H–related proteins 1 and 5 correlate with disease activity in IgA nephropathy(2017)141 cited
→ Frequency of anti-recipient alloreactive helper T-cell precursors in donor blood and graft-versus-host disease after HLA-identical sibling bone-marrow transplantation(1993)134 cited
→ Microcirculation Inflammation Associates With Outcome in Renal Transplant Patients With De Novo Donor-Specific Antibodies(2012)109 cited

→ Cytomegalovirus seropositivity adversely influences outcome after T‐depleted unrelated donor transplant in patients with chronic myeloid leukaemia: the case for tailored graft‐versus‐host disease prophylaxis(2001)106 cited

→ Postanastomotic Transplant Renal Artery Stenosis: Association With De Novo Class II Donor-Specific Antibodies(2013)65 cited

→ Preformed Complement-Activating Low-Level Donor-Specific Antibody Predicts Early Antibody-Mediated Rejection in Renal Allografts(2012)65 cited

→ THE ROLE OF THE ALLOGRAFT IN THE INDUCTION OF DONOR-SPECIFIC T CELL HYPORESPONSIVENESS(2001)59 cited